Spots Global Cancer Trial Database for sprycel
Every month we try and update this database with for sprycel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer | NCT00903006 | Breast Cancer | Fulvestrant MK-0646 Dasatinib | 18 Years - | M.D. Anderson Cancer Center | |
| Ph I Dasatinib + Erlotinib in Recurrent MG | NCT00609999 | Glioblastoma Gliosarcoma | Erlotinib and D... | 18 Years - | Duke University | |
| Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL) | NCT01724879 | Philadelphia Po... | Dasatinib | 18 Years - 55 Years | Goethe University | |
| Study of Erlotinib in Combination With Dasatinib | NCT00895128 | Advanced Cancer | Erlotinib Hydro... Dasatinib | 18 Years - | M.D. Anderson Cancer Center | |
| Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer | NCT00903006 | Breast Cancer | Fulvestrant MK-0646 Dasatinib | 18 Years - | M.D. Anderson Cancer Center | |
| Gemcitabine and Dasatinib in Advanced Solid Tumors | NCT00429234 | Advanced Cancer Solid Tumors | Dasatinib Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
| XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib | NCT00920868 | Solid Tumor Metastatic Colo... | dasatinib bevacizumab Oxaliplatin Capecitabine | 18 Years - | Duke University | |
| Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia | NCT00895297 | Chronic Myeloid... | Dasatinib (Spry... | 18 Years - | European Society for Blood and Marrow Transplantation | |
| XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib | NCT00920868 | Solid Tumor Metastatic Colo... | dasatinib bevacizumab Oxaliplatin Capecitabine | 18 Years - | Duke University | |
| An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) | NCT01498445 | Leukemia | Dasatinib Decitabine Decitabine | 18 Years - | M.D. Anderson Cancer Center | |
| FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer | NCT00501410 | Colorectal Canc... | 5-FU Cetuximab Dasatinib Leucovorin Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies | NCT01015222 | Advanced Cancer | Dasatinib Bevacizumab Paclitaxel | - | M.D. Anderson Cancer Center | |
| Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma | NCT00734864 | Glioblastoma Mu... Gliosarcoma Anaplastic Astr... Anaplastic Olig... Glioma | enzyme-inducing... enzyme-inducing... | 18 Years - | Duke University | |
| Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma | NCT00734864 | Glioblastoma Mu... Gliosarcoma Anaplastic Astr... Anaplastic Olig... Glioma | enzyme-inducing... enzyme-inducing... | 18 Years - | Duke University | |
| Gemcitabine and Dasatinib in Advanced Solid Tumors | NCT00429234 | Advanced Cancer Solid Tumors | Dasatinib Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma | NCT01092728 | Melanoma | Dasatinib Surgical Resect... | 18 Years - | M.D. Anderson Cancer Center | |
| Dasatinib and Crizotinib in Advanced Cancer | NCT01744652 | Advanced Cancer... | Crizotinib Dasatinib | 16 Years - | M.D. Anderson Cancer Center | |
| Personalized Treatment Selection for Metastatic Breast Cancer | NCT00780676 | Breast Cancer | Dasatinib AZD6244 | 18 Years - | M.D. Anderson Cancer Center | |
| Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies | NCT01015222 | Advanced Cancer | Dasatinib Bevacizumab Paclitaxel | - | M.D. Anderson Cancer Center | |
| Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma | NCT00895960 | Glioblastoma CNS Disease Brain Diseases | Dasatinib RT (Radiotherap... TMZ (Temozolomi... | 18 Years - | M.D. Anderson Cancer Center | |
| Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma | NCT01092728 | Melanoma | Dasatinib Surgical Resect... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia | NCT00829647 | Chronic Lymphoc... Leukemia | dasatinib and l... | 18 Years - | Scripps Health | |
| Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer | NCT01471106 | Breast Cancer | Dasatinib | 18 Years - | M.D. Anderson Cancer Center | |
| Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer | NCT01471106 | Breast Cancer | Dasatinib | 18 Years - | M.D. Anderson Cancer Center | |
| Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma | NCT00734864 | Glioblastoma Mu... Gliosarcoma Anaplastic Astr... Anaplastic Olig... Glioma | enzyme-inducing... enzyme-inducing... | 18 Years - | Duke University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
